Sleep Apnea Devices companies

  • Report ID: 183
  • Published Date: Sep 29, 2025
  • Report Format: PDF, PPT

Sleep Apnea Devices Market Players:

    The market is witnessing a high intensity of competition and is anticipated to continue to do so in the near future. The revenue share of the global sleep apnea devices market is vastly distributed, which makes the industry highly fragmented. As a result, the scope of new entrants increases. Product innovation is the common area of focus of all the small and large key players associated with the market. The key players in the market not only conduct research and development on their own, but also take assistance from professional bodies, including industry experts and research institutions, for the advancement of sleep apnea devices.

    The following is the list of the key players dominating the global sleep apnea devices market:

    • ResMed
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Koninklijke Philips N.V.
    • Fisher & Paykel Healthcare Limited
    • Inspire Medical Systems, Inc.
    • SomnoMed
    • Drive DeVilbiss Healthcare
    • Compumedics Limited
    • Löwenstein Medical
    • BMC Medical Co., Ltd.
    • Nihon Kohden Corporation
    • Natus Medical Incorporated:
    • Cadwell Industries, Inc.
    • Braebon Medical Corporation
    • Medtronic
    • LivaNova PLC

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In 2025, the industry size of the sleep apnea market is over USD 8.9 billion.

The size of the sleep apnea devices market is projected to reach USD 21.4 billion by the end of 2036, expanding at a CAGR of 9.2% during the forecast period, i.e., between 2026-2036.

The major players in the market are ResMed, Koninklijke Philips N.V., Fisher & Paykel Healthcare Limited, Inspire Medical Systems, Inc., SomnoMed, and Drive DeVilbiss Healthcare.

The therapeutic devices segment is anticipated to garner the largest market share of 76.2% by 2036 and display lucrative growth opportunities during 2026-2036.

The market in North America is projected to hold the largest market share of 46.7% by the end of 2036 and provide more business opportunities in the future.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos